Malondialdehyde, 8-iso-prostaglandin F2α, and lipid profile alterations in COVID-19 patients: insights from South-Western Nigeria.

Ebesunun MO, Ozegbe DU, Nwaejigh PC, Orimadegun BE, Okeoma OI

Open source

DOI
10.1186/s12879-026-12622-1
Published
2026 Jan 20
Container
BMC infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-026-12622-1,
  title = {Malondialdehyde, 8-iso-prostaglandin F2α, and lipid profile alterations in COVID-19 patients: insights from South-Western Nigeria.},
  author = {Ebesunun MO and Ozegbe DU and Nwaejigh PC and Orimadegun BE and Okeoma OI},
  year = {2026},
  journal = {BMC infectious diseases},
  doi = {10.1186/s12879-026-12622-1},
  url = {https://doi.org/10.1186/s12879-026-12622-1}
}

RIS

TY  - JOUR
TI  - Malondialdehyde, 8-iso-prostaglandin F2α, and lipid profile alterations in COVID-19 patients: insights from South-Western Nigeria.
AU  - Ebesunun MO
AU  - Ozegbe DU
AU  - Nwaejigh PC
AU  - Orimadegun BE
AU  - Okeoma OI
PY  - 2026
JO  - BMC infectious diseases
DO  - 10.1186/s12879-026-12622-1
UR  - https://doi.org/10.1186/s12879-026-12622-1
ER  - 

APA

MO, E., DU, O., PC, N., BE, O., & OI, O. (2026). Malondialdehyde, 8-iso-prostaglandin F2α, and lipid profile alterations in COVID-19 patients: insights from South-Western Nigeria.. BMC infectious diseases. https://doi.org/10.1186/s12879-026-12622-1

Source records